Is American Tower Stock Undervalued?
The market action of late has been nothing short of…
Sell
27
AGNG Quote, Financials, Valuation and Earnings
Last price:
$30.05
Seasonality move
:
1.94%
Day range:
$29.99 - $30.33
52-week range:
$28.00 - $33.64
Dividend yield:
0.83%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
12.4K
Avg. volume:
5.2K
1-year change:
4.33%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AGNG
Global X Aging Population ETF
|
$30.10 | -- | -- | -- | $0.15 | 0.83% | -- |
|
EDOC
Global X Telemedicine & Digital Health ETF
|
$10.10 | -- | -- | -- | $0.00 | 0% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$9.98 | -- | -- | -- | $0.00 | 0% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$28.99 | -- | -- | -- | $0.47 | 0.49% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.41 | -- | -- | -- | $0.00 | 0% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.91 | -- | -- | -- | $0.33 | 5.43% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AGNG
Global X Aging Population ETF
|
-- | 1.018 | -- | -- |
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | 1.617 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 2.174 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.482 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.470 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.988 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
Global X Aging Population ETF vs. Competitors
-
Which has Higher Returns AGNG or EDOC?
Global X Telemedicine & Digital Health ETF has a net margin of -- compared to Global X Aging Population ETF's net margin of --. Global X Aging Population ETF's return on equity of -- beat Global X Telemedicine & Digital Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AGNGGlobal X Aging Population ETF-- -- -- EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -
What do Analysts Say About AGNG or EDOC?
Global X Aging Population ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Telemedicine & Digital Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Aging Population ETF has higher upside potential than Global X Telemedicine & Digital Health ETF, analysts believe Global X Aging Population ETF is more attractive than Global X Telemedicine & Digital Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings AGNGGlobal X Aging Population ETF0 0 0 EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 -
Is AGNG or EDOC More Risky?
Global X Aging Population ETF has a beta of 0.780, which suggesting that the stock is 21.991% less volatile than S&P 500. In comparison Global X Telemedicine & Digital Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AGNG or EDOC?
Global X Aging Population ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 0.83%. Global X Telemedicine & Digital Health ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Aging Population ETF pays -- of its earnings as a dividend. Global X Telemedicine & Digital Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AGNG or EDOC?
Global X Aging Population ETF quarterly revenues are --, which are smaller than Global X Telemedicine & Digital Health ETF quarterly revenues of --. Global X Aging Population ETF's net income of -- is lower than Global X Telemedicine & Digital Health ETF's net income of --. Notably, Global X Aging Population ETF's price-to-earnings ratio is -- while Global X Telemedicine & Digital Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Aging Population ETF is -- versus -- for Global X Telemedicine & Digital Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AGNGGlobal X Aging Population ETF-- -- -- -- EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- --
-
Which has Higher Returns AGNG or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X Aging Population ETF's net margin of --. Global X Aging Population ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AGNGGlobal X Aging Population ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About AGNG or GNOM?
Global X Aging Population ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Aging Population ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X Aging Population ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings AGNGGlobal X Aging Population ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is AGNG or GNOM More Risky?
Global X Aging Population ETF has a beta of 0.780, which suggesting that the stock is 21.991% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.142, suggesting its more volatile than the S&P 500 by 14.178%.
-
Which is a Better Dividend Stock AGNG or GNOM?
Global X Aging Population ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 0.83%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Aging Population ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AGNG or GNOM?
Global X Aging Population ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X Aging Population ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X Aging Population ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Aging Population ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AGNGGlobal X Aging Population ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns AGNG or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Global X Aging Population ETF's net margin of --. Global X Aging Population ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AGNGGlobal X Aging Population ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About AGNG or HRTS?
Global X Aging Population ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Aging Population ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Global X Aging Population ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings AGNGGlobal X Aging Population ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is AGNG or HRTS More Risky?
Global X Aging Population ETF has a beta of 0.780, which suggesting that the stock is 21.991% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AGNG or HRTS?
Global X Aging Population ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 0.83%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. Global X Aging Population ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AGNG or HRTS?
Global X Aging Population ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Global X Aging Population ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Global X Aging Population ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Aging Population ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AGNGGlobal X Aging Population ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns AGNG or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Global X Aging Population ETF's net margin of --. Global X Aging Population ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AGNGGlobal X Aging Population ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About AGNG or HTEC?
Global X Aging Population ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Aging Population ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Global X Aging Population ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings AGNGGlobal X Aging Population ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is AGNG or HTEC More Risky?
Global X Aging Population ETF has a beta of 0.780, which suggesting that the stock is 21.991% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.075, suggesting its more volatile than the S&P 500 by 7.497%.
-
Which is a Better Dividend Stock AGNG or HTEC?
Global X Aging Population ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 0.83%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Aging Population ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AGNG or HTEC?
Global X Aging Population ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Global X Aging Population ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Global X Aging Population ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Aging Population ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AGNGGlobal X Aging Population ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns AGNG or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to Global X Aging Population ETF's net margin of --. Global X Aging Population ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AGNGGlobal X Aging Population ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About AGNG or JDOC?
Global X Aging Population ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Aging Population ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe Global X Aging Population ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings AGNGGlobal X Aging Population ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is AGNG or JDOC More Risky?
Global X Aging Population ETF has a beta of 0.780, which suggesting that the stock is 21.991% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AGNG or JDOC?
Global X Aging Population ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 0.83%. JPMorgan Healthcare Leaders ETF offers a yield of 5.43% to investors and pays a quarterly dividend of $0.33 per share. Global X Aging Population ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AGNG or JDOC?
Global X Aging Population ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. Global X Aging Population ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, Global X Aging Population ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Aging Population ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AGNGGlobal X Aging Population ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock Overvalued?
The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…
4 Top Dividend Stocks to Buy Now
If you’re looking for steady income, dividend stocks are a…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
